Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 1
1959 1
1960 1
1961 3
1962 2
1963 7
1964 7
1965 9
1966 12
1967 16
1968 10
1969 10
1970 12
1971 10
1972 11
1973 12
1974 23
1975 17
1976 14
1977 21
1978 18
1979 21
1980 23
1981 29
1982 26
1983 26
1984 35
1985 37
1986 48
1987 38
1988 39
1989 49
1990 62
1991 58
1992 71
1993 81
1994 73
1995 77
1996 83
1997 94
1998 107
1999 111
2000 133
2001 121
2002 130
2003 133
2004 125
2005 147
2006 149
2007 149
2008 156
2009 164
2010 173
2011 214
2012 202
2013 197
2014 226
2015 203
2016 224
2017 246
2018 266
2019 319
2020 344
2021 337
2022 314
2023 298
2024 302
2025 328
2026 79

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,468 results

Results by year

Filters applied: . Clear all
Page 1
Schizophrenia and cognitive dysfunction.
Takeda T, Umehara H, Matsumoto Y, Yoshida T, Nakataki M, Numata S. Takeda T, et al. Among authors: matsumoto y. J Med Invest. 2024;71(3.4):205-209. doi: 10.2152/jmi.71.205. J Med Invest. 2024. PMID: 39462553 Free article. Review.
Microbiota-driven antitumour immunity mediated by dendritic cell migration.
Lin NY, Fukuoka S, Koyama S, Motooka D, Tourlousse DM, Shigeno Y, Matsumoto Y, Yamano H, Murotomi K, Tamaki H, Irie T, Sugiyama E, Kumagai S, Itahashi K, Tanegashima T, Fujimaki K, Ito S, Shindo M, Tsuji T, Wake H, Watanabe K, Maeda Y, Enokida T, Tahara M, Yamashita R, Fujisawa T, Nomura M, Kawazoe A, Goto K, Doi T, Shitara K, Mano H, Sekiguchi Y, Nakamura S, Benno Y, Nishikawa H. Lin NY, et al. Among authors: matsumoto y. Nature. 2025 Aug;644(8078):1058-1068. doi: 10.1038/s41586-025-09249-8. Epub 2025 Jul 14. Nature. 2025. PMID: 40659786 Free PMC article.
The real-world impact of biologics for NMOSD: A retrospective single-center study compared with natural course and conventional treatments in Japanese.
Yamazaki N, Misu T, Matsumoto Y, Takai Y, Namatame C, Ono H, Kaneko K, Nishiyama S, Kuroda H, Takahashi T, Nakashima I, Fujihara K, Aoki M. Yamazaki N, et al. Among authors: matsumoto y. Mult Scler Relat Disord. 2024 Dec;92:106176. doi: 10.1016/j.msard.2024.106176. Epub 2024 Nov 16. Mult Scler Relat Disord. 2024. PMID: 39579645
Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study.
Akbari H, Bakas S, Sako C, Fathi Kazerooni A, Villanueva-Meyer J, Garcia JA, Mamourian E, Liu F, Cao Q, Shinohara RT, Baid U, Getka A, Pati S, Singh A, Calabrese E, Chang S, Rudie J, Sotiras A, LaMontagne P, Marcus DS, Milchenko M, Nazeri A, Balana C, Capellades J, Puig J, Badve C, Barnholtz-Sloan JS, Sloan AE, Vadmal V, Waite K, Ak M, Colen RR, Park YW, Ahn SS, Chang JH, Choi YS, Lee SK, Alexander GS, Ali AS, Dicker AP, Flanders AE, Liem S, Lombardo J, Shi W, Shukla G, Griffith B, Poisson LM, Rogers LR, Kotrotsou A, Booth TC, Jain R, Lee M, Mahajan A, Chakravarti A, Palmer JD, DiCostanzo D, Fathallah-Shaykh H, Cepeda S, Santonocito OS, Di Stefano AL, Wiestler B, Melhem ER, Woodworth GF, Tiwari P, Valdes P, Matsumoto Y, Otani Y, Imoto R, Aboian M, Koizumi S, Kurozumi K, Kawakatsu T, Alexander K, Satgunaseelan L, Rulseh AM, Bagley SJ, Bilello M, Binder ZA, Brem S, Desai AS, Lustig RA, Maloney E, Prior T, Amankulor N, Nasrallah MP, O'Rourke DM, Mohan S, Davatzikos C; ReSPOND consortium. Akbari H, et al. Among authors: matsumoto y. Neuro Oncol. 2025 May 15;27(4):1102-1115. doi: 10.1093/neuonc/noae260. Neuro Oncol. 2025. PMID: 39665363 Free PMC article.
Randomized Controlled Trial of Cilostazol Addition for In-Stent Restenosis After Carotid Artery Stenting.
Yamagami H, Ozaki T, Ogasawara K, Nagata I, Matsumaru Y, Yoshimura S, Sasaki M, Nagatsuka K, Minematsu K, Nagai Y, Sakai C, Matsumoto Y, Ezura M, Ishihara H, Sakai N; CAS-CARE Investigators. Yamagami H, et al. Among authors: matsumoto y. Stroke. 2024 Dec;55(12):2776-2785. doi: 10.1161/STROKEAHA.124.047210. Epub 2024 Nov 25. Stroke. 2024. PMID: 39585936 Free article. Clinical Trial.
Lubiprostone in chronic kidney disease: Insights into mitochondrial function and polyamines from a randomized phase 2 clinical trial.
Watanabe S, Nakayama M, Yokoo T, Sanada S, Ubara Y, Komatsuda A, Asanuma K, Suzuki Y, Konta T, Kazama JJ, Suzuki T, Fukuda S, Soga T, Yamada T, Mizutani S, Matsumoto M, Naito Y, Taguchi K, Fukami K, Kashiwagi H, Kikuchi K, Suzuki C, Tokuno H, Urasato M, Kujirai R, Matsumoto Y, Akiyama Y, Tomioka Y, Itai S, Tongu Y, Mishima E, Kawabe C, Kasahara T, Ogata Y, Toyohara T, Sato T, Tanaka T, Abe T; LUBI-CKD TRIAL Investigators. Watanabe S, et al. Among authors: matsumoto y. Sci Adv. 2025 Aug 29;11(35):eadw3934. doi: 10.1126/sciadv.adw3934. Epub 2025 Aug 29. Sci Adv. 2025. PMID: 40880481 Free PMC article. Clinical Trial.
Different Complement Activation Patterns Following C5 Cleavage in MOGAD and AQP4-IgG+NMOSD.
Kaneko K, Kuroda H, Matsumoto Y, Sakamoto N, Yamazaki N, Yamamoto N, Umezawa S, Namatame C, Ono H, Takai Y, Takahashi T, Fujimori J, Nakashima I, Harigaya Y, Lassmann H, Fujihara K, Misu T, Aoki M. Kaneko K, et al. Among authors: matsumoto y. Neurol Neuroimmunol Neuroinflamm. 2024 Sep;11(5):e200293. doi: 10.1212/NXI.0000000000200293. Epub 2024 Aug 12. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39133885 Free PMC article.
6,468 results